BEIJING MED PHARM CORP (BJGP) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 165 transactions totaling $9.4M, demonstrating a bearish sentiment with -$8.4M in net insider flow. The most recent transaction on Feb 24, 2011 involved a transaction of 711,373 shares valued at $7.1M.
No significant insider buying has been recorded for BJGP in the recent period.
No significant insider selling has been recorded for BJGP in the recent period.
Based on recent SEC filings, insider sentiment for BJGP is bearish with an Insider Alignment Score of 5/100 and a net flow of -$8.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at BEIJING MED PHARM CORP (BJGP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading BJGP stock, having executed 165 transactions in the past 90 days. The most active insider is Zhijun Tong (Executive), who has made 1 transactions totaling $40.0M.
Get notified when executives and directors at BJGP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 24, 2011 | Gao David | Executive | Disposition | 711,373 | $10.00 | $7.1M | Large |
| Feb 24, 2011 | P. Harrington Daniel | Executive | Disposition | 1,154,602 | $10.00 | $11.5M | Large |
| Feb 24, 2011 | P. Harrington Daniel | Executive | Disposition | 10,000 | $10.00 | $100.0K | |
| Feb 24, 2011 | P. Harrington Daniel | Executive | Disposition | 17,385 | $10.00 | $173.8K | |
| Feb 24, 2011 | R. Baledge Les | Executive | Disposition | 1,413,897 | $10.00 | $14.1M | Large |
| Feb 24, 2011 | R. Baledge Les | Executive | Disposition | 22,000 | $10.00 | $220.0K | |
| Feb 24, 2011 | R. Baledge Les | Executive | Disposition | 8,000 | $10.00 | $80.0K | |
| Feb 24, 2011 | M. Powell Fred | Executive | Disposition | 2,500 | $10.00 | $25.0K | |
| Feb 24, 2011 | J. Hollendoner Frank | Executive | Disposition | 27,005 | $10.00 | $270.1K | |
| Feb 24, 2011 | W. Stakes John | Executive | Disposition | 15,750 | $10.00 | $157.5K | |
| Feb 24, 2011 | Tong Zhijun | Executive | Disposition | 4,000,000 | $10.00 | $40.0M | Large |
| Feb 24, 2011 | D. Greenacre Martyn | Executive | Disposition | 22,000 | $10.00 | $220.0K | |
| Aug 17, 2009 | J. Hollendoner Frank | Executive | Purchase | 5,000 | $3.92 | $19.6K | |
| Aug 17, 2009 | Han Zhiqiang | Executive | Purchase | 1,162 | $3.90 | $4.5K | |
| Aug 17, 2009 | Han Zhiqiang | Executive | Purchase | 2,300 | $3.90 | $9.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 12 | $74.0M | 87.7% |
Sale(S) | 107 | $8.9M | 10.5% |
Exercise (Options)(X) | 1 | $938.2K | 1.1% |
Purchase(P) | 41 | $486.0K | 0.6% |
Exercise(M) | 1 | $57.5K | 0.1% |
Other(J) | 3 | $0 | 0.0% |
Insider selling pressure at BEIJING MED PHARM CORP has increased, with 11 insiders executing 165 transactions across all time. Total sales of $8.9M significantly outpace purchases of $486.0K, resulting in a net outflow of $8.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.